Dr. Davidson has served as a member of our Board of Directors since December 2023. Dr. Davidson is a medical oncologist and researcher who is a top opinion leader in the field of breast cancer biology and treatment, with a particular interest in developing evidence-based clinical pathways in breast cancer treatment. She is currently the Executive Vice President for Clinical Affairs, Raisbeck Chair for Collaborative Research and Professor of Fred Hutchinson Cancer Center (“FHCC”). Dr. Davidson also serves as a Professor at the University of Washington Department of Medicine based in Seattle where she previously held the role of Head of the Division of Medical Oncology from December 2016 to August 2023. During this time, Dr. Davidson served as the President and Executive Director of the Seattle Cancer Care Alliance from December 2016 to April 2022. Prior to joining FHCC, she spent time at the National Cancer Institute, Johns Hopkins in Baltimore and the University of Pittsburgh. Dr. Davidson is a past-President of both the American Society of Oncology and the American Association for Cancer Research and has served on a variety of board of directors and advisory committees in the oncology field. She has authored more than 400 publications during her career and has received many awards, honors, and appointments. These include: The Brinker International Award for Breast Cancer Research, the Rosalind E. Franklin Award for Women in Science from the National Cancer Institute (2008), and election to the National Academy of Medicine (2011) and the American Academy of Arts and Sciences (2019). She has also been listed among Thomson Reuters Highly Cited Researchers (2014-2015). After receiving a BA in Molecular Biology from Wellesley College, she went on to obtain an MD from Harvard Medical School. Dr. Davidson completed her residency in Internal Medicine at John Hopkins Hospital and a fellowship at the National Cancer Institute.